| Real-life experience of using conventional diseasemodifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use o | Aicha BOURAOUİ, Euthalia ROUSSOU | 1–10 |
| Efficacy and safety of aceclofenac in osteoarthritis: A meta-analysis of randomized controlled trials | Parvati B. PATEL, Tejas K. PATEL | 11–18 |
| Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity | Rasha Mohamed FAWZY, Nashwa Ismail HASHAAD, Abeer Ahmed Abo ELAZEM, Mohamed Ibrahim YOUSSEF | 19–23 |
| Subclinical enthesopathy in patients with psoriasis and its association with other disease parameters: a power Doppler ultrasonographic study | Abdelhafeez MOSHRİF, Ahmed MOSALLAM, Essam elden M. MOHAMED, Wesam GOUDA, Mostafa DOMA | 24–28 |
| IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role | Warren RAYMOND, Gro OSTLİ-EİLERTSEN, Sheynae GRİFFİTHS, Johannes NOSSENT | 29–35 |
| Investigation of joint hypermobility in individuals with hyperbilirubinemia | Muhammet ÇINAR, Sedat YILMAZ, Kadir ÖZTÜRK, Ayhan DİNÇ, İbrahim ÇETİNDAĞLI, Mustafa ÇAKAR | 36–39 |
| Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis | Veli YAZISIZ, Hatice YAZISIZ, Fatih BORLU, Ahmet BEHLÜL, Sıdıka GÜLKAN ÖZKAN, Yüksel Aslı GÖKBELEN | 40–45 |
| An overview and management of osteoporosis | Lale ÖZIŞIK, Nursel ÇALIK BAŞARAN, Tümay SÖZEN | 46–56 |
| Viscosupplementation of the knee: Three cases of acute Pseudoseptic Arthritis with painful and irritating complications and a literature review | Güray TOĞRAL, Güle AYDIN, Onur VARIŞ, Murat AYDIN, Murat ARIKAN | 59–62 |
| Acute digital ischemia: A rare presentation of antisynthetase syndrome | Jin Ei CHAN, Sandeep PALAKODETİ, Matthew J. KOSTER | 63–65 |
|